ERRICO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 723
EU - Europa 517
AS - Asia 161
AF - Africa 57
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.464
Nazione #
US - Stati Uniti d'America 707
IT - Italia 278
CN - Cina 105
NL - Olanda 66
CI - Costa d'Avorio 57
IE - Irlanda 56
DE - Germania 36
VN - Vietnam 36
FI - Finlandia 35
CA - Canada 16
HK - Hong Kong 12
FR - Francia 9
MT - Malta 7
SE - Svezia 6
GB - Regno Unito 5
UA - Ucraina 5
BR - Brasile 3
CH - Svizzera 3
TR - Turchia 3
CL - Cile 2
ID - Indonesia 2
IN - India 2
PL - Polonia 2
BE - Belgio 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ES - Italia 1
EU - Europa 1
HU - Ungheria 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 1.464
Città #
Chandler 152
Millbury 70
Amsterdam 66
Napoli 57
Princeton 38
Dong Ket 36
Des Moines 35
Nanjing 35
Ashburn 34
Naples 23
Beijing 20
Boston 18
Lawrence 15
Ottawa 15
Salerno 13
Wilmington 13
Hong Kong 12
Shenyang 12
Changsha 10
Nanchang 8
Melita 7
Norwalk 6
Dearborn 5
Jiaxing 5
Mugnano Di Napoli 5
Nocera Superiore 5
Quartu Sant'elena 5
Tianjin 5
Caserta 4
Chicago 4
Dublin 4
Kyiv 4
Lombard 4
Manassas 4
San Francisco 4
Scafati 4
Formia 3
Indiana 3
Milan 3
Pozzuoli 3
São Paulo 3
Tappahannock 3
Acerra 2
Altavilla Silentina 2
Bari 2
Brusciano 2
Como 2
Confienza 2
Ficarazzi 2
Istanbul 2
Jacksonville 2
Lappeenranta 2
Redwood City 2
Romainville 2
Rome 2
Somma Vesuviana 2
Torino 2
Zhengzhou 2
Zurich 2
Atlanta 1
Aversa 1
Barcelona 1
Basel 1
Brussels 1
Budapest 1
Buffalo 1
Buonabitacolo 1
Cambridge 1
Cascina 1
Castrovillari 1
Cecina 1
Chengdu 1
Clearwater 1
Crispano 1
Duncan 1
Fairfield 1
Falls Church 1
Florence 1
Frankfurt am Main 1
Giugliano In Campania 1
Guangzhou 1
Hangzhou 1
Hebei 1
Horia 1
Kronberg 1
Kunming 1
Leawood 1
Limatola 1
Livorno 1
London 1
Los Angeles 1
Marano 1
Monmouth Junction 1
Montreal 1
Mumbai 1
New York 1
Nocera Inferiore 1
Palermo 1
Piano di Sorrento 1
Pisa 1
Totale 850
Nome #
Tracking the evolution of epialleles during neural differentiation and brain development: D-Aspartate oxidase as a model gene 118
DNA methylation landscape of the genes regulating D-serine and D-aspartate metabolism in post-mortem brain from controls and subjects with schizophrenia [*Keller S., Punzo D., Cuomo M co-primi autori] 91
Selective demethylation of two CpG sites causes postnatal activation of the Dao gene and consequent removal of D-serine within the mouse cerebellum 65
Quantitative determination of free D-Asp, L-Asp and N-methyl-D-aspartate in mouse brain tissues by chiral separation and Multiple Reaction Monitoring tandem mass spectrometry 62
D-aspartate dysregulation in Ddo-/- mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum 55
A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice 47
Age-Related Changes in D-Aspartate Oxidase Promoter Methylation Control Extracellular D-Aspartate Levels and Prevent Precocious Cell Death during Brain Aging 45
DNA methylation state of BDNF gene is not altered in prefrontal cortex and striatum of schizophrenia subjects. 44
Prenatal and Early Postnatal Cerebral d -Aspartate Depletion Influences l -Amino Acid Pathways, Bioenergetic processes, and Developmental Brain Metabolism 40
A physiological mechanism to regulate D-aspartic acid and NMDA levels in mammals revealed by D-aspartate oxidase deficient mice. 39
d-Aspartate: An endogenous NMDA receptor agonist enriched in the developing brain with potential involvement in schizophrenia 38
Decreased free d-aspartate levels are linked to enhanced d-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patients 36
Decreased levels of d-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia 35
Decreased Rhes mRNA levels in the brain of patients with Parkinson’s disease and MPTP- treated macaques 34
D-Aspartate Prevents Corticostriatal Long-Term Depression and Attenuates Schizophrenia-Like Symptoms Induced by Amphetamine and MK-801 32
D-aspartate modulates nociceptive-specific neuron activity and pain threshold in inflammatory and neuropathic pain condition in mice 32
D-aspartate: an atypical amino acid with neuromodulatory activity in mammals. 31
Rasd2 Modulates Prefronto-Striatal Phenotypes in Humans and ‘Schizophrenia-Like Behaviors’ in Mice 30
Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia 29
Dysfunctional dopaminergic neurotransmission in asocial BTBR mice 29
Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post‐Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients 28
Bimodal effect of D-aspartate on brain aging processes: insights from animal models. 27
D-Aspartate oxidase influences glutamatergic system homeostasis in mammalian brain 27
A fast and sensitive method for measuring picomole levels of total free amino acids in very small amounts of biological tissues. 26
Dysfunctional D-aspartate metabolism in BTBR mouse model of idiopathic autism 24
Higher free d-aspartate and N-methyl-d-aspartate levels prevent striatal depotentiation and anticipate l-DOPA-induced dyskinesia 23
Increased d-aspartate brain content rescues hippocampal age-related synaptic plasticity deterioration of mice 23
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 22
Prenatal expression of d-aspartate oxidase causes early cerebral d-aspartate depletion and influences brain morphology and cognitive functions at adulthood 22
D-aspartate oxidase gene duplication induces social recognition memory deficit in mice and intellectual disabilities in humans 22
The Emerging Role of Altered D-Aspartate Metabolism in Schizophrenia: New Insights From Preclinical Models and Human Studies 21
New insights on the role of free d-aspartate in the mammalian brain 21
Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA?induced dyskinesia 21
New insights on the influence of free D-aspartate metabolism in the mammalian brain during prenatal and postnatal life 21
Cerebrospinal fluid and serum D-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease 21
The role of D-aspartic acid and N-methyl-D-aspartic acid in the regulation of prolactin release. 20
Role of Aberrant Striatal Dopamine D1 Receptor/cAMP/Protein Kinase A/DARPP32 Signaling in the Paradoxical Calming Effect of Amphetamine 20
Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals 19
Increased levels of d-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility. 18
Voluntary Exercise and Sucrose Consumption Enhance Cannabinoid CB1 Receptor Sensitivity in the Striatum 17
Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion 17
The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons. 16
Thyroid Hormones and D-Aspartic Acid, D-Aspartate Oxidase, D-Aspartate Racemase, H2O2, and ROS in Rats and Mice 16
Profile of gantenerumab and its potential in the treatment of Alzheimer's disease 16
Persistent elevation of D-Aspartate enhances NMDA receptor-mediated responses in mouse substantia nigra pars compacta dopamine neurons 15
Abnormal RasGRP1 Expression in the Post-Mortem Brain and Blood Serum of Schizophrenia Patients 15
Persistent increase of d-aspartate in d-aspartate oxidase mutant mice induces a precocious hippocampal age-dependent synaptic plasticity and spatial memory decay 14
Olanzapine, but not clozapine, increases glutamate release in the prefrontal cortex of freely moving mice by inhibiting D-aspartate oxidase activity 14
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis 13
Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain 13
New evidence on the role of d‐aspartate metabolism in regulating brain and endocrine system physiology: From preclinical observations to clinical applications 12
High performance liquid chromatography determination of l-glutamate, l-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer’s disease 11
Free D-aspartate triggers NMDA receptor-dependent cell death in primary cortical neurons and perturbs JNK activation, Tau phosphorylation, and protein SUMOylation in the cerebral cortex of mice lacking D-aspartate oxidase activity 10
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients 10
D-Aspartate Depletion Perturbs Steroidogenesis and Spermatogenesis in Mice 4
Nusinersen Induces Disease-Severity-Specific Neurometabolic Effects in Spinal Muscular Atrophy 3
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients 3
Totale 1.577
Categoria #
all - tutte 6.473
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.473


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201913 0 0 0 0 0 0 0 0 0 0 3 10
2019/2020177 69 5 6 1 29 9 9 1 4 9 29 6
2020/2021123 3 0 4 2 2 23 11 10 15 2 4 47
2021/2022348 2 10 10 2 3 9 0 15 67 22 75 133
2022/2023420 54 46 10 13 42 38 18 39 43 71 36 10
2023/2024246 17 51 32 9 18 15 12 81 6 5 0 0
Totale 1.577